CarmenCalfaMD

Oncology • Plantation, FL

Breast Cancer

Physician

Join to view full profile

Dr. Calfa is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Calfa's full profile

Already have an account?

Office
8100 SW Tenth St
Plantation, FL 33324
Phone+1 954-210-1000

Education & Training

University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 2005 - 2008
University of Miami/Jackson Health SystemResidency, Internal Medicine, 2001 - 2004
University of Tirgu-Mures Faculty of MedicineClass of 1995

Certifications & Licensure

FL State Medical License 2008 - 2026

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer Start of enrollment: 2013 Nov 01
Completed
Phase 2
Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer Start of enrollment: 2017 Mar 31
Active, not recruiting
Phase 2

Publications & Presentations

PubMed

34 citations
Palbociclib in Patients With Non–Small-Cell Lung Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study
Eugene R Ahn, Pam K. Mangat, Elizabeth Garrett-Mayer, Susan Halabi, Elie G. Dib
JCO Precision Oncology. 2020-06-25
32 citations
Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Pro...
Julie Gottlieb Fisher, David Tait, Elizabeth Garrett-Mayer, Susan Halabi, Pam K. Mangat
Targeted Oncology. 2020-10-22
11 citations
Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study.
Herbert L Duvivier, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Eugene R Ahn
Journal of Clinical Oncology. 2023-11-20

Press Mentions

Breast Cancer Deaths in the US Continue to Fall, but New Report Warns of Rise in Cases Among Women Younger Than 50October 1st, 2024
Study Shows Fewer Breast Cancer Deaths Overall—but Cases Are Rising in Younger WomenOctober 1st, 2024
BriaCell Presents Clinical Efficacy Data at ASCO 2024June 3rd, 2024
Join now to see all